Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pamiparib by BeiGene for Peritoneal Cancer: Likelihood of Approval
Pamiparib is under clinical development by BeiGene and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II...
Pamiparib by BeiGene for Non-Small Cell Lung Cancer: Likelihood of Approval
Pamiparib is under clinical development by BeiGene and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Pamiparib by BeiGene for Fallopian Tube Cancer: Likelihood of Approval
Pamiparib is under clinical development by BeiGene and currently in Phase II for Fallopian Tube Cancer. According to GlobalData, Phase...
Pamiparib by BeiGene for Ovarian Cancer: Likelihood of Approval
Pamiparib is under clinical development by BeiGene and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
Pamiparib by BeiGene for Endometrial Cancer: Likelihood of Approval
Pamiparib is under clinical development by BeiGene and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II...